Global Diabetic Neuropathy Market 2014-2018

2014-05-09
Price :
Published : May-2014
No. of Pages : 55

Report Description

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Pfizer Inc.
16.1.1 Business Overview
16.1.2 Key Information
16.1.3 SWOT Analysis
16.2 Eli Lilly and Company
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Janssen Pharmaceuticals Inc.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis

17. Pipeline Analysis
17.1 Phase III Analysis
17.2 Phase II Analysis
17.3 Phase I Analysis
17.4 Discontinued Projects
17.5 Projects on Hold
17.6 Promising Pipeline Molecules
17.6.1 Phase III Promising Pipeline Molecules
17.6.2 Phase II Promising Pipeline Molecules
17.7 Other First-in-class Pipeline Molecules:

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Diabetic Neuropathy Market 2013-2018 (US$ billion)
Exhibit 3: Global Diabetic Neuropathy Market by Geographical Segmentation 2013
Exhibit 4: Eli Lilly and Company: Business Segmentation
Exhibit 5: Diabetic Neuropathy Pipeline Snapshot 2013
Exhibit 6: Discontinued Pipeline Molecules on the basis of MOA

Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Pharmaceutical Packaging Market in Europe 2015-2019

Pharmaceutical packaging products are used to protect pharmaceuticals from contamination by external toxins and microbial activity, and to extend their shelf life. Also, drug manufacturers need to comply with international packaging regulations. Various raw materials such as plastic resins, glass, paper and paperboard, aluminum, and other metals are used in the production of pharmaceutical packaging. They are available as bottles, parenteral containers, blister packs, caps, closures, pre-fillable syringes, and tubes. The key end-customers of these packaging products are manufacturers of pharmaceuticals. The analysts forecast pharmaceutical packaging market in Europe to grow at a CAGR of 7.26 percent over the period 2014-2019. Covered in this report The pharmaceutical packaging mar......
$2500

Telemedicine Market in BRIC 2015-2019

Telemedicine is defined as the application of telecommunication technology to provide clinical healthcare to patients, particularly in remote patient care. There are various technologies and devices such as cameras, internet, satellites, and wireless communication that are used to provide telemedicine services, for instance, videoconferencing. Telemedicine provides clinical care services mainly through two technologies: pre-captured and real-time. Telemedicine helps eliminate distance barriers and improves access to medical services that would often not be easily accessible in rural areas. Moreover, it helps save lives in critical care and emergency situations. The analysts forecast telemedicine market in BRIC to grow at a CAGR of 16.14% over the period 2014-2019. Covered in this rep......
$2500

Pharmaceutical Packaging Market in North America 2015-2019

Packaging products are meant to protect perishable goods from damage and contamination. Pharmaceutical packaging products have strong barrier properties, are meant to be portable, and are available in both unit dosage and multi-dose formats. International regulations regarding safe drug delivery are enforced by regulatory bodies on drug manufacturers, which in turn fuels adoption of sustainable packaging. Various raw materials such as plastic resins, glass, paper and paperboard, and aluminum and other metals are used in the manufacture of pharmaceutical packaging. These packages are available in a variety of dimensions and forms. The analysts forecast pharmaceutical packaging market in North America to grow at a CAGR of 5.31 percent over the period 2014-2019. Covered in this Report ......
$2500

Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019

SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of flare-ups and remissions and can range from mild to life threatening in severity. No cure for SLE yet exists. The analysts forecast Global SLE Drugs market to grow at a CAGR of 22.41 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the gr......
$2500

Pharmaceutical Logistics Market in the APAC 2015-2019

Logistics deals with the procurement, planning, and implementation of activities in the forward and reverse logistics chain of an organization. The pharmaceutical industry uses logistics for the complete management of the way resources are acquired, stored, and moved to different end-user locations. The use of logistics helps the pharmaceutical industry to have a continual supply of drugs, equipment, and devices from suppliers and distributors in different locations. The analysts forecast the pharmaceutical logistics market in the APAC to grow at a CAGR of 10.45% over the period 2014-2019. Covered in this Report The report covers present scenario and the growth prospects of the pharmaceutical logistics market in the APAC for the period 2015-2019. The market is segmented based on t......
$2500

Global Gastrointestinal OTC Drugs Market 2015-2019

OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country. The analysts forecast global gastrointestinal OTC drugs market to grow at a CAGR of 1.48% ove......
$2500

Global Inflammatory Bowel Disease Market 2015-2019

Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss. Inflammatory bowel disease can also prove to be life-threatening for the patients. Ulcerative colitis generally affects the colon, where inflammation and ulcers develop in the innermost lining of the colon and the rectum of a patient. Crohn's disease causes inflammation of the lining of the GI tract. The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or b......
$3000

Global Pompe Disease Market 2015-2019

Pompe disease is a type of LSD. LSD refers to a group of diseases arising from the accumulation of specific substrates. LSDs are progressive and have variable age of onset and clinical symptoms. LSDs are inherited autosomal recessive disorders. Pompe disease has two broad sub-types: infantile-onset Pompe disease and adult-onset Pompe disease. Pompe disease occurs as a result of mutations in the GAA gene. These mutations are responsible for the preventing the action of the enzyme acid alpha-glucosidase, which is responsible for catabolizing glycogen, thereby allowing sugar to accumulate and reach toxic levels in the lysosomes of cells. The buildup of glycogen in certain organs and tissues, mostly in the muscles, hinders the normal functions of organs. Pompe disease is an autosomal recessive......
$2500

Healthcare IT (HIT) Market in the APAC Region 2015-2019

Healthcare providers are leveraging the usage of IT in their business processes. It has changed the way hospitals and physicians work; from the automation of simple processes in the Healthcare sector to its integration with the entire value chain of the Healthcare sector, HIT has come a long way. This development is focused on the Healthcare sector becoming more patient-centric. The analysts forecast HIT Market in APAC to grow at a CAGR of 16 percent over the period 2014-2019. Covered in this Report The HIT Market in APAC is categorized into two segments: Clinical IT and Non-clinical IT. This break-up is done on the basis of advanced nations and developing nations. The report, Healthcare IT (HIT) Market in the APAC Region 2015-2019, has been prepared based on an in-depth market......
$3000

Global Biomedical Metal Market 2015-2019

Biomedical metals are being used for a number of applications in the Medical sector. The metals commonly used are stainless steel, titanium-based alloys, cobalt-based alloys, nitinol, magnesium and related metals. Stainless steel is the most widely used metal because of its biocompatibility and cost-effectiveness. Biomedical metal find a wide range of applications in implants, surgical instruments, dental, trauma fixations, and other biomedical applications. The analysts forecast Global Biomedical Metal market to grow at a CAGR of 7.27 percent over the period 2014-2019. Covered in this Report The Global Biomedical Metal market can be segmented on the basis of type of biomedical metal: Stainless steel, Titanium-based Alloy, Cobalt-based Alloy, Magnesium, and Others, where stainless......
$2500